A collection of news and information related to Genentech Inc. published by this site and its partners.
Displaying items 1-12 of 57 » View latimes.com items only1 2 3 4 5 Next >
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...
WASHINGTON — With less than a week to go before President Obama is sworn in for his second term, fundraisers for the presidential inaugural committee were still working Monday to secure their goal of $50 million in private donations to finance the...
One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...
SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006. The giant social network plans to unveil the redesign at a press conference Thursday at its Menlo Park, Calif.,...
In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...
Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members. Roche’s current offer of $51 per Illumina...
TechnologyIn the first change to Apple's boardroom since the death of Steve Jobs last month, the company announced that Walt Disney Co. President and Chief Executive Robert Iger will be the Cupertino electronics maker's newest board member....
Opinion L.A.Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
L.A. Times Tech BlogWhat does Steve Jobs' chairman role mean for Apple?: Steve Jobs' resignation as Apple Inc.'s CEO might seem like a step out of the spotlight at the world's largest company. But it is possible that little may change in the executive shuffle and in fact,...
L.A. Times Tech BlogSteve Jobs has resigned as Apple's CEO and COO Tim Cook is set to take over: Steve Jobs has resigned his post as CEO at Apple Inc. Tim Cook, Apple's chief operating officer who has been filling in for Jobs since the company co-founder took his second...
Los Angeles TimesFor the first time in a quarter of a century, researchers have identified a new treatment for diabetic macular edema, a potentially blinding disorder that affects about 1 million Americans, researchers said Tuesday. The treatment uses a drug called...
May 12, 2013 |Story| Los Angeles Times
Mar 29, 2013 |Story| Los Angeles Times
Jan 14, 2013 |Story| Los Angeles Times
Mar 17, 2013 |Story| Los Angeles Times
Mar 6, 2013 |Story| Los Angeles Times
Jan 30, 2012 |Story| Los Angeles Times
Apr 18, 2012 |Story| Los Angeles Times
Nov 15, 2011 | Los Angeles Times
Jun 28, 2011 | Los Angeles Times
Aug 24, 2011 | Los Angeles Times
Aug 24, 2011 | Los Angeles Times
Apr 28, 2010 |Story| Los Angeles Times
Original site for Genentech Inc. topic gallery.